CONTEXT: Spinal cord injury (SCI) results in a loss of function and sensation below the level of the lesion. Neuroprosthetic technology has been developed to help restore motor and autonomic functions as well as to provide sensory feedback. FINDINGS: This paper provides an overview of neuroprosthetic technology that aims to address the priorities for functional restoration as defined by individuals with SCI. We describe neuroprostheses that are in various stages of preclinical development, clinical testing, and commercialization including functional electrical stimulators, epidural and intraspinal microstimulation, bladder neuroprosthesis, and cortical stimulation for restoring sensation. We also discuss neural recording technologies that may provide command or feedback signals for neuroprosthetic devices. CONCLUSION/CLINICAL RELEVANCE: Neuroprostheses have begun to address the priorities of individuals with SCI, although there remains room for improvement. In addition to continued technological improvements, closing the loop between the technology and the user may help provide intuitive device control with high levels of performance.
CONTEXT: Spinal cord injury (SCI) results in a loss of function and sensation below the level of the lesion. Neuroprosthetic technology has been developed to help restore motor and autonomic functions as well as to provide sensory feedback. FINDINGS: This paper provides an overview of neuroprosthetic technology that aims to address the priorities for functional restoration as defined by individuals with SCI. We describe neuroprostheses that are in various stages of preclinical development, clinical testing, and commercialization including functional electrical stimulators, epidural and intraspinal microstimulation, bladder neuroprosthesis, and cortical stimulation for restoring sensation. We also discuss neural recording technologies that may provide command or feedback signals for neuroprosthetic devices. CONCLUSION/CLINICAL RELEVANCE: Neuroprostheses have begun to address the priorities of individuals with SCI, although there remains room for improvement. In addition to continued technological improvements, closing the loop between the technology and the user may help provide intuitive device control with high levels of performance.
Authors: Vikash Gilja; Cindy A Chestek; Ilka Diester; Jaimie M Henderson; Karl Deisseroth; Krishna V Shenoy Journal: IEEE Trans Biomed Eng Date: 2011-01-20 Impact factor: 4.538
Authors: Lisa Guevremont; Costantino G Renzi; Jonathan A Norton; Jan Kowalczewski; Rajiv Saigal; Vivian K Mushahwar Journal: IEEE Trans Neural Syst Rehabil Eng Date: 2006-09 Impact factor: 3.802
Authors: Benjamin Abelson; Steve Majerus; Daniel Sun; Bradley C Gill; Eboo Versi; Margot S Damaser Journal: Nat Rev Urol Date: 2019-05 Impact factor: 14.432
Authors: Zachariah J Sperry; Kyounghwan Na; Saman S Parizi; Hillel J Chiel; John Seymour; Euisik Yoon; Tim M Bruns Journal: J Neural Eng Date: 2018-03-09 Impact factor: 5.379
Authors: Christine H Blabe; Vikash Gilja; Cindy A Chestek; Krishna V Shenoy; Kim D Anderson; Jaimie M Henderson Journal: J Neural Eng Date: 2015-07-14 Impact factor: 5.379
Authors: Mijail D Serruya; James P Harris; Dayo O Adewole; Laura A Struzyna; Justin C Burrell; Ashley Nemes; Dmitriy Petrov; Reuben H Kraft; H Isaac Chen; John A Wolf; D Kacy Cullen Journal: Adv Funct Mater Date: 2017-09-04 Impact factor: 18.808